Genetics
Today’s eugenics is much more dangerous
Scientific progress, demographics, geopolitics and the decline of Christianity are weakening our moral defences against the misuse of genetics
Be cured or have kids: Tough choice for sickle-cell patients
WHEN Celenise Mahmood first learned about two new gene therapies that could cure sickle-cell disease, she felt a wave of relief.
Genetic-testing firm Invitae, backed by SoftBank and Cathie Wood, files for bankruptcy
INVITAE, a genetic-testing company with backers including SoftBank Group and Cathie Wood’s Ark Investment Management, has filed for bankruptcy as the DNA testing industry struggles to regain investor ...
Moderna, Bayer-backed startup Metagenomi files for US IPO
Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna, filed for an initial public offering (IPO) in the United States on Friday (Jan 5).
Why do we choose the jobs we do? Maybe it’s in our genes
From a young age, children start to have ideas about their future occupations. When they reach their twenties, they contemplate their dream careers. Years later, a lot of them may consider a mid-caree...
Sculptures both macabre and moving
Patricia Piccinini’s hyper-realist sculptures imagine human beings bonding with cyborgs and genetically modified creatures

Gene editing 'blocks virus transmission' in human cells
[PARIS] Scientists have used Crispr gene-editing technology to successfully block the transmission of the Sars-CoV-2 virus in infected human cells, according to research released Tuesday that could pa...
WHO details steps to ensure human gene editing is safe, ethical
[GENEVA] The World Health Organization published a slew of recommendations on Monday on how to ensure gene editing research is used for the public good and does not get out of hand.

23andMe DNA-testing firm goes public following Branson deal
[NEW YORK] DNA-testing company 23andMe, which has doubled down on its effort to prove consumer genetics offers more than entertainment value, began publicly trading on Nasdaq Thursday under the ticker...